Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Neurology
|
November 1, 1986
Allopurinol and severe epilepsy
P DeMarco, P Zagnoni
Neuropsychobiology
|
January 1, 1988
Allopurinol in severe epilepsy. A preliminary report
P De Marco, P Zagnoni
Neuropsychobiology
|
January 1, 1989
Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients
W G Sannita, L Gervasio, P Zagnoni
Pharmacological Research Communications
|
March 1, 1985
Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessment
L Bertoli, I Busnardo, C Borghi, et al.
Minerva Medica
|
November 10, 1981
[Frequency of risk factors in cerebrovascular disease and their effect on the course and outcome. Study on 423 hospitalized patients]
A Cognazzo, E Grasso, P C Gerbino Promis, et al.
Minerva Medica
|
November 10, 1981
[Plasma levels of anti-epileptic drugs. Evaluation of determinations carried out in the years 1978-1979]
P Zagnoni, A Cognazzo, P C Gerbino Promis, et al.
Minerva Psichiatrica
|
April 1, 1991
[Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study]
P L Cabras, E Enriques, A Casini, et al.
Italian Journal of Neurological Sciences
|
July 1, 1982
Epileptic seizures and lipoma of the corpus callosum
E Grasso, P C Gerbino Promis, A Cognazzo, et al.
International Journal of Clinical Pharmacology and Biopharmacy
|
September 1, 1977
Plasma levels of di-no-propylacetate and clonazepam in epileptic patients
A Baruzzi, B Bordo, L Bossi, et al.
Monographs in Neural Sciences
|
January 1, 1980
Antiepileptic drug therapy and plasma levels in 2500 patients from Northern Italy
P Zagnoni, L Leone, A Baruzzi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Neurology
|
November 1, 1986
Allopurinol and severe epilepsy
P DeMarco, P Zagnoni
Neuropsychobiology
|
January 1, 1988
Allopurinol in severe epilepsy. A preliminary report
P De Marco, P Zagnoni
Neuropsychobiology
|
January 1, 1989
Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients
W G Sannita, L Gervasio, P Zagnoni
Pharmacological Research Communications
|
March 1, 1985
Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessment
L Bertoli, I Busnardo, C Borghi, et al.
Minerva Medica
|
November 10, 1981
[Frequency of risk factors in cerebrovascular disease and their effect on the course and outcome. Study on 423 hospitalized patients]
A Cognazzo, E Grasso, P C Gerbino Promis, et al.
Minerva Medica
|
November 10, 1981
[Plasma levels of anti-epileptic drugs. Evaluation of determinations carried out in the years 1978-1979]
P Zagnoni, A Cognazzo, P C Gerbino Promis, et al.
Minerva Psichiatrica
|
April 1, 1991
[Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study]
P L Cabras, E Enriques, A Casini, et al.
Italian Journal of Neurological Sciences
|
July 1, 1982
Epileptic seizures and lipoma of the corpus callosum
E Grasso, P C Gerbino Promis, A Cognazzo, et al.
International Journal of Clinical Pharmacology and Biopharmacy
|
September 1, 1977
Plasma levels of di-no-propylacetate and clonazepam in epileptic patients
A Baruzzi, B Bordo, L Bossi, et al.
Monographs in Neural Sciences
|
January 1, 1980
Antiepileptic drug therapy and plasma levels in 2500 patients from Northern Italy
P Zagnoni, L Leone, A Baruzzi, et al.
Page
of 2